Robert W. Baird Increases Smartstop Self Storage REIT (NYSE:SMA) Price Target to $37.00

Smartstop Self Storage REIT (NYSE:SMA) had its price objective increased by analysts at Robert W. Baird from $36.00 to $37.00 in a report issued on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the healthcare company’s stock. Robert W. Baird’s price target points to a potential upside of 7.57% from the stock’s current price.

A number of other brokerages have also commented on SMA. Raymond James Financial assumed coverage on shares of Smartstop Self Storage REIT in a research note on Wednesday, July 15th. They set a “strong-buy” rating and a $39.00 price target for the company. Zacks Research upgraded shares of Smartstop Self Storage REIT from a “strong sell” rating to a “hold” rating in a report on Friday, May 8th. Wells Fargo & Company reiterated a “neutral” rating on shares of Smartstop Self Storage REIT in a report on Friday, July 24th. Finally, Weiss Ratings upgraded shares of Smartstop Self Storage REIT from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 16th. Two analysts have rated the stock with a Strong Buy rating, four have given a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $36.56.

Smartstop Self Storage REIT Stock Up 0.3%

Shares of NYSE:SMA opened at $34.40 on Monday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 5.33 and a current ratio of 5.28. Smartstop Self Storage REIT has a 52-week low of $29.41 and a 52-week high of $39.77. The business’s 50 day simple moving average is $33.06 and its two-hundred day simple moving average is $32.29. The firm has a market cap of $1.90 billion, a P/E ratio of 67.44 and a beta of 0.50.

Smartstop Self Storage REIT (NYSE:SMA) last released its quarterly earnings data on Wednesday, August 5th. The healthcare company reported $0.20 EPS for the quarter, missing the consensus estimate of $0.49 by ($0.29). Smartstop Self Storage REIT had a net margin of 9.68% and a return on equity of 2.33%. The firm had revenue of $79.28 million for the quarter. Smartstop Self Storage REIT has set its FY 2026 guidance at 1.980-2.040 EPS. As a group, research analysts forecast that Smartstop Self Storage REIT will post 2 EPS for the current fiscal year.

Hedge Funds Weigh In On Smartstop Self Storage REIT

Hedge funds have recently bought and sold shares of the company. Rockland Trust Co. bought a new stake in shares of Smartstop Self Storage REIT in the 2nd quarter worth $208,000. Western Wealth Management LLC bought a new position in shares of Smartstop Self Storage REIT during the first quarter valued at about $153,000. Bank of America Corp DE lifted its position in shares of Smartstop Self Storage REIT by 53.4% during the first quarter. Bank of America Corp DE now owns 222,586 shares of the healthcare company’s stock valued at $6,740,000 after purchasing an additional 77,479 shares in the last quarter. Amundi purchased a new position in Smartstop Self Storage REIT during the first quarter worth about $714,000. Finally, California State Teachers Retirement System boosted its holdings in Smartstop Self Storage REIT by 134.7% during the first quarter. California State Teachers Retirement System now owns 69,654 shares of the healthcare company’s stock worth $2,109,000 after purchasing an additional 39,975 shares during the last quarter.

Smartstop Self Storage REIT Company Profile

Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry.